Biochemical and immunological characterization of ceruloplasmin genetic variants. A proposed model for quantitative control.
D000918:Antibody Specificity; D001386:Azides / Q000494:pharmacology; D044383:Black People; D001797:Blood Protein Electrophoresis; D002570:Ceruloplasmin / Q000037:antagonists & inhibitors / Q000097:blood* / Q000145:classification; D002850:Chromatography, Gel; D002951:Citrates / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D006579:Heterozygote; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D008722:Methods; D008954:Models, Biological; D008967:Molecular Biology; D008970:Molecular Weight; D009439:Neuraminidase / Q000494:pharmacology; D010641:Phenotype; D012964:Sodium / Q000494:pharmacology; D013194:Staining and Labeling
D001386:Azides; D002951:Citrates; D003486:Cyanides; D007106:Immune Sera; D012964:Sodium; D002570:Ceruloplasmin; D009439:Neuraminidase